R
Raffaele Bruno
Researcher at University of Pavia
Publications - 322
Citations - 14690
Raffaele Bruno is an academic researcher from University of Pavia. The author has contributed to research in topics: Medicine & Hepatitis C. The author has an hindex of 52, co-authored 275 publications receiving 11262 citations. Previous affiliations of Raffaele Bruno include University of Modena and Reggio Emilia.
Papers
More filters
Journal ArticleDOI
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
Luca Arcaini,Sara Burcheri,A. Rossi,Marco Paulli,Raffaele Bruno,Francesco Passamonti,Ercole Brusamolino,Alfredo Molteni,Alessandro Pulsoni,Mc Cox,Lorella Orsucci,Alberto Fabbri,Maurizio Frezzato,Mt Voso,Francesco Zaja,Francesca Montanari,Michele Merli,Cristiana Pascutto,E. Morra,Sergio Cortelazzo,M. Lazzarino +20 more
TL;DR: Hematitis C virus-positive nongastric marginal zone lymphomas of MALT show an indolent course similar to HCV-negative patients and seem an ideal target for exploiting the antilymphoma activity of antiviral treatments.
Journal ArticleDOI
Viral dynamics and pharmacokinetics of peginterferon alpha-2a and peginterferon alpha-2b in naive patients with chronic hepatitis c: a randomized, controlled study.
Raffaele Bruno,Paolo Sacchi,Valentina Ciappina,Cristina Zochetti,S.F.A. Patruno,Laura Maiocchi,Gaetano Filice +6 more
TL;DR: Once-weekly administration of peginterferon alpha-2b (1.0 microg/kg/wk) may be insufficient for continuous interferon exposure; twice- weekly administration may help avoid increases in viral replication as interferons levels decline.
Journal ArticleDOI
Consensus conference on TIPS management: Techniques, indications, contraindications.
Stefano Fagiuoli,Raffaele Bruno,Wilma Debernardi Venon,Filippo Schepis,Francesco Vizzutti,Pierluigi Toniutto,Marco Senzolo,Paolo Caraceni,Francesco Salerno,Paolo Angeli,Roberto Cioni,Alessandro Vitale,Maurizio Grosso,Andrea De Gasperi,Gennaro D'Amico,Alfredo Marzano +15 more
TL;DR: The trans jugular intrahepatic Porto systemic shunt (TIPS) is no longer viewed as a salvage therapy or a bridge to liver transplantation and is currently indicated for a number of conditions related to portal hypertension with positive results in survival.
Journal ArticleDOI
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART.
Antonella d'Arminio Monforte,Roberto Bugarini,Patrizio Pezzotti,Andrea De Luca,Andrea Antinori,Cristina Mussini,Gian Marco Vigevani,Umberto Tirelli,Raffaele Bruno,Francesco Gritti,Marcello Piazza,Silvia Chigiotti,Antonio Chirianni,Carlo De Stefano,Eligio Pizzigallo,Oreste Perrella,Mauro Moroni +16 more
TL;DR: Hepatitis C coinfection and elevated ALT levels at HAART initiation are important predictors of progression to alanine aminotransferase levels > or =200 IU/L; stavudine-containing regimens were associated with a lower risk compared with zidovudineThe Lancet records suggest that highly active antiretroviral therapy is strongly effective in reducing morbidity and mortality in HIV-1-positive individuals.
Journal ArticleDOI
Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms.
Sergio Giuseppe Vancheri,Giovanni Savietto,Francesco Ballati,Alessia Maggi,Costanza Canino,Chandra Bortolotto,Adele Valentini,Roberto Dore,Giulia Maria Stella,Angelo Corsico,Giorgio Antonio Iotti,Francesco Mojoli,Stefano Perlini,Raffaele Bruno,Lorenzo Preda +14 more
TL;DR: The predominant lung changes were GGO and reticular alteration, while consolidation was less frequent, and the typical distribution pattern was bilateral, peripheral, or both peripheral and central and involved predominantly the lower and middle fields.